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7METHODOLOGY ARTICLE Open AccessNitric oxide induces cell death in canine cruciate
ligament cells by activation of tyrosine kinase and
reactive oxygen species
Simone Forterre1*, Andreas Zurbriggen2 and David Spreng1Abstract
Background: There is increasing evidence suggesting that development of progressive canine cranial cruciate
ligament (CCL) rupture involves a gradual degeneration of the CCL itself, initiated by a combination of factors,
ranging from mechanical to biochemical. To date, knowledge is lacking to what extent cruciate disease results from
abnormal biomechanics on a normal ligament or contrary how far preliminary alterations of the ligament due to
biochemical factors provoke abnormal biomechanics. This study is focused on nitric oxide (NO), one of the
potential biochemical factors. The NO-donor sodium nitroprusside (SNP) has been used to study NO-dependent cell
death in canine cranial and caudal cruciate ligament cells and to characterize signaling mechanisms during NO-
stimulation.
Results: Sodium nitroprusside increased apoptotic cell death dose- and time-dependently in cruciate
ligamentocytes. Cells from the CCL were more susceptible to apoptosis than CaCL cells. Caspase-3 processing in
response to SNP was not detected. Testing major upstream and signal transducing pathways, NO-induced cruciate
ligament cell death seemed to be mediated on different levels. Specific inhibition of tyrosine kinase significantly
decreased SNP-induced cell death. Mitogen activated protein kinase ERK1 and 2 are activated upon NO and
provide anti-apoptotic signals whereas p38 kinase and protein kinase C are not involved. Moreover, data showed
that the inhibition reactive oxygen species (ROS) significantly reduced the level of cruciate ligament cell death.
Conclusions: Our data support the hypothesis that canine cruciate ligamentocytes, independently from their origin
(CCL or CaCL) follow crucial signaling pathways involved in NO-induced cell death. However, the difference on
susceptibility upon NO-mediated apoptosis seems to be dependent on other pathways than on these tested in the
present study. In both, CCL and CaCL, the activation of the tyrosine kinase and the generation of ROS reveal
important signaling pathways. In perspective, new efforts to prevent the development and progression of cruciate
disease may include strategies aimed at reducing ROS.
Keywords: Cranial cruciate ligament rupture, Dogs, Apoptosis, Nitric oxide, Sodium nitroprusside, Reactive oxygen
species, Tyrosine kinaseBackground
Cranial cruciate ligament (CCL) rupture is one of the
most common orthopedic diseases among dogs and an
important cause of osteoarthritis (OA). The majority of
dogs rupture their CCL during normal daily activities
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reproduction in any medium, provided the orligament itself [1]. Mechanical factors such as straight
tibial plateau angle, distal femoral torsion, tibial torsion,
as well as intercondylar notch stenosis have been asso-
ciated with CCL disease [2-4]. There is no doubt that
biomechanical factors, among others, are likely to play
an important role in the disease process [5] but the true
effect on the ethiopathogenesis is currently unknown.
There is strong evidence that the degenerative changes
observed in CCL disease are due to a combination of
factors, ranging from mechanical to biochemical.
Developmental, immune-mediated disorders, geneticl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of cells and extracellular matrix have been implicated as
biological factors [6-8]. To date, knowledge is lacking to
what extent cruciate disease results from abnormal bio-
mechanics on a normal ligament or contrary how far
preliminary alterations of the ligament due to biochem-
ical factors provoke abnormal biomechanics. A lot of re-
search has focused on stifle joint stabilization as
therapeutical intervention but markedly less studies
investigated the role of biochemical factors.
Nitric oxide (NO) is one of these biochemical factors
considered to be involved in the canine cruciate disease
and to influence apoptosis in the CCL [9,10]. Under nor-
mal physiological conditions low levels of NO are pro-
duced by constitutive nitric oxide synthases (cNOS) to
regulate a number of homeostatic processes, whereas the
generation of larger quantities of NO by inducible NOS
(iNOS) accounts for an inflammatory setting [11]. The
role of NO has been investigated excessively in cartilage.
Studies demonstrate that NO increases the number of
chondrocyte death, which correlates with the extent of
cartilage degradation in human OA [12-14] as well as in
experimental induced OA in rabbits [15] and in dogs
[16,17]. Most studies linking NO and chondrocyte death
are based on the use of exogenous NO-donors such as so-
dium nitroprusside (SNP) [13,15,18,19]. Nitric oxide has
been shown to affect crucial intracellular signaling path-
ways in various human and animal cells of the joint
[13,19-21]. In contrast to cartilage tissue, only a few stud-
ies investigated the impact of NO on the degeneration of
the canine CCL [9,10,22,23], although in the CCL of dogs
an excess production of NO has been documented [9].
Furthermore, the intracellular signaling by which NO
mediates apoptosis in the CCL remains to be elucidated.
The objective of the presented study was to test the
hypothesis that known NO-mediated signaling pathways
from chondrocytes or synoviocytes are also activated in
canine cruciate ligament cells. In a previous study our
group demonstrated a different susceptibility to apop-
tosis between CCL and caudal cruciate ligament (CaCL)
cells [24]. In order to prove if a relationship between
susceptibility and signaling exists, we examined specific
intracellular signaling pathways involved in NO-induced
cell death in canine CCL and CaCL cells. Because there
is no recent literature of the NO-pathways in canine
cruciate ligamentocytes, specifically ligamentocyte cul-
tures, we decided to compare our results also to publica-
tions on human and rabbit joint tissue cultures.
Methods
Materials
All reagents for the tissue preparation and assays were
purchased from Sigma-Aldrich (Buchs, Switzerland) un-
less otherwise stated. Sodium nitroprusside (SNP),SB-202190, SN-50, and NS-398 were purchased from
Enzo Life Sciences (Lausen, Switzerland). Carboxy-
PTIO, taxifolin, genistein (4,5,7-Trihydroxyisoflavone),
calphostin C, and uric acid were from Calbiochem
(Merck, Switzerland). PD98059 was obtained from Cell
Signaling (BioConcept, Allschwil, Switzerland).
Cell preparation
Tissues from the CCL and CaCL of 8 one day-old beagle
dogs (5 male, 3 female) were obtained within 1 h of death
in accordance with review board approval by the Animal
Care and Experimentation Committee of the Canton of
Bern, Switzerland (No 56/06). Ligaments were harvested
under aseptic conditions and placed in sterile DMEM
medium. A portion of the ligament at both the tibial and
femoral ends was trimmed and discarded. The outer syn-
ovial layer was removed via sharp dissection and the liga-
ments were cut into 0.1 – 0.2 mm pieces. For cruciate
ligamentocyte isolation, canine CCL and CaCL pieces
were digested with collagenase type IV and cultivated in
DMEM supplemented with 15% fetal calf serum (FCS),
250 μM ascorbic acid and antibiotics as previously
reported [24]. At 80% confluence, cells were harvested
after trypsin/EDTA treatment and frozen in 20% FCS and
10% DMSO until use. After thawing and passaging again,
cells from the fourth passage were synchronized by 10%
FCS-DMEM for 1 day and then used in the following
experiments. Cell cultures up to the fifth passage were
investigated to confirm purity using specific fibroblast
antibodies. Canine cruciate ligamentocytes were identified
by immunohistochemistry with antibodies against fibro-
nectin (F3648) and collagen I (6308, Abcam, USA) and
compared to the staining in explants of CCL and CaCL of
dogs as described before [24]. Human OA chondrocytes
(kindly provided by S. Kohl) served as positive controls for
prostaglandin (PG) E2 measurements.
Experimental culture conditions
Because of its ability to induce apoptosis in canine cruci-
ate ligamentocytes, SNP was chosen as a pro-apoptotic
agent. For the experiments on the SNP dose response,
cells were treated with various concentrations of SNP in
10% FCS-DMEM for 18 h. A time course of response
was also investigated by incubating cells with SNP for
the indicated time period (6–24 h). To explore signaling
cascades in SNP-induced cell death, inhibitors of differ-
ent pathways were used as mentioned below. Therefore,
canine cruciate ligamentocytes (40 × 103 cells/96-well
for MTT or 106 cells/6-well for flow cytometry and
immunoblot) were preincubated with each inhibitor for
2 h, and then SNP concentrations (0–0.5 mM; as indi-
cated) was added directly to the cultures and allowed to
incubate for an additional 18-hour period in 10% FCS-
DMEM. Cytotoxicity and cell death were always
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course assay), using the assays described below.
Inhibitors
The role of caspases was investigated by using a pancaspase
inhibitor zVAD.fmk (0–100 μM). To assess the involvement
of protein kinases, we used calphostin C (25 nM), SB
202190 (10 μM), and PD98059 (10 μM). SN-50 (0–50 μM)
and PDTC (0–10 μM) were applied to investigate the role
of nuclear translocation of NF-kB. Genistein (50 μM) was
used as a tyrosine kinase inhibitor. To explore the effect of
oxidative stress/free radicals in NO-mediated ligamentocyte
apoptosis, scavengers for peroxynitrite (ONOO-) (uric acid,
0–2 mM), NO (carboxy-PTIO, 0–12.5 μM), and super-
oxide/hydrogen peroxide (O2
-/H2O2) (taxifolin, 0–100 μM)
were used. The COX-2 inhibitor NS-398 (0–100 μM) was
used to examine the role of endogenously synthesized
PGE2. Preliminary experiments were used to find inhibitor
concentrations inducing maximal response in our study
(data not shown). These different inhibitors were tested up
to the maximal concentrations that were effective under the
actual experimental conditions.
Cytotoxicity assay
Cytotoxicity was determined as a function of the cellular
conversion of the tetrazolium salt 3-(4,5-Dimethylthiazol-
2-yl)-2,5-diphenyltetrazoliumbromid (MTT) into a DMSO
soluble formazan product that was measured at 490 nm in
a microplate reader (EL 800, BioTek, USA) as described
before [24]. In all experiments using this assay, results
were expressed as a reduction of cell viability (% of control
cell cultures without any treatment) using the following
formula with OD as optical density: Cell viability
(%) = 100 × (Sample OD – Blank OD/Control OD – Blank
OD).
Apoptosis assay
Flow cytometry with fluorescein isothiocyanate (FITC)-
conjugated annexin V and propidium iodide double
staining was used to identify apoptotic cell death (FACS
LRII, BD Biosciences). This assay allows detection of
apoptotic cells by Annexin V binding, executed simul-
taneously with propidium iodide as a dye exclusion test
[25]. Briefly, floating cells were collected and adherent
cells were cautiously detached using trypsin/PBS. The
cells were pooled, centrifuged at 1500 rpm and 4°C for
6 min. After decanting the supernatant, cells were resus-
pended in 800 μL ice-cold annexin V labeling buffer
(10 mM HEPES, 140 mM NaCl, 2.5 mM CaCl2) for
washing. After a second centrifugation, the pellets were
resuspended in 100 μL annexin V labeling buffer added
with FITC-conjugated annexin V to a final concentration
of 0.1 μg/mL and incubated for 30 min at 4°C. Counter-
staining with 5 μg propidium iodide/mL cell suspensionwas done 1 min before analyzing. Cell stained FITC-
Annexin V positive and propidium iodide negative were
detected as early apoptotic cells, demonstrating Annexin
V binding and cytoplasmic membrane integrity. Late
apoptotic cells and necrotic cells show Annexin V bind-
ing and propidium iodide uptake due to loss of cell
membrane integrity and leakage of cellular constituents.
Data files were generated for 5×104 cells or more per
sample using the FlowJo V7.1 Analysis Software (Trees-
tar Inc., Ashland, OR, USA).
Western immunoblot of COX-2 and cleaved caspase-3
For COX-2 and cleaved caspase-3 detection, canine cru-
ciate ligamentocytes were lysed in RIPA buffer for
30 min. Twenty μg supernatant proteins were separated
onto 12% Tris–HCl acrylamide gel and transferred onto
nitrocellulose membrane. The membranes were blocked
with 5% nonfat dry milk in TBS with 0.1% Tween-20, for
1 h at RT. The membranes were probed overnight at
4°C with a primary antibody (rabbit polyclonal anti mur-
ine COX-2, Cayman, 1:200, or rabbit monoclonal anti
human cleaved caspase-3 (Asp175), Cell Signaling,
1:1000, both in 5% nonfat dry milk, TBS, 0.1% Tween-
20). Thereafter blots were probed with the correspond-
ing secondary antibody, goat-anti-rabbit Ig (HRP)
(1:3000, DAKO, Switzerland). Immunoreactive signals
were visualized by the ECL system (GE Healthcare,
Switzerland) according to the manufacturer`s protocol.
Prostaglandin E2 production
Prostaglandin E2 was determined in culture medium
supernatants by the PGE2 EIA Kit following the com-
pany`s protocol (Cayman Chemical, Michigan, USA).
Quantification of bcl-2 protein levels
Canine cruciate ligamentocytes were seeded at 106 cells
per well in a 6-well plate in 2 mL 10% FCS-DMEM and
cultured until confluence. Cells were treated with differ-
ent inhibitors and various concentrations of SNP. The
bcl-2 protein levels of adherent cells were assayed using
commercially available kits (human bcl-2 ELISA kit,
Abnova, Germany) according to the manufacturer`s
instructions. The level of bcl-2 was expressed in ng per
milligram of total protein.
Statistical analysis
All statistical analyses were accomplished using NCSS
2007 Statistical Software (www.ncss.com). Each data
point represented the mean± SD, of n different cell lines
(i.e., donors) each performed in triplicates. Data normal-
ity was evaluated using the Shapiro-Wilk test. One-way
analysis of variance (ANOVA) with post hoc Dunnett`s
multiple comparisons was used for statistical comparisons
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Results and discussion
Evidence documenting NO as a crucial mediator for ca-
nine CCL disease prompted our investigations to the
underlying signaling of NO-induced cell death in cruciate
ligamentocytes. Cruciate ligamentocytes are not only the
sites of NO-production [9,22] but are also themselves tar-
gets for NO and undergo apoptosis upon exposure to high
concentrations of NO [24]. Although CCL and CaCL have
the same extrasynovial environment, apparently the same
nutrition and blood supply, incidence of rupture differs
between the ligaments. The rationale for using cells from
the CCL as well as from the CaCL was that in a previous
study we found different susceptibilities to apoptosis [24].
However, a comparison of the effect of pathway inhibitors
on NO-induced cell death did not showed any significant
differences between CCL and CaCL cells suggesting that
the varying susceptibilities are not related to the signaling
cascades which were analyzed below.
Role of caspase-independent apoptosis and bcl-2 down-
regulation in CCL and CaCL cells
Cultures of canine cruciate ligamentocytes were stimu-
lated with increasing concentrations of SNP, and cell via-
bility was assessed by MTT assay and flow cytometry. A
dose-dependent loss of cell viability was induced by SNP
in CCL and CaCL cells (Figure 1). Using the double
staining FITC-labeled Annexin V and propidium iodide
flow cytometry, we could corroborate that CCL and
CaCL cells died by apoptosis (Figure 2). Comparing CCL
and CaCL cells, it became obvious that CaCL cells wereFigure 1 Dose-dependent effect of SNP on cell viability in canine cruci
of SNP (mM) for 18 h. Cell viability of (dark gray square) CCL and □ CaCL cells
in the M&M section. Control cells were not treated with SNP. The graphs data
four different cell donors, each performed in triplicates. * P< 0.05, ** P< 0.01less susceptible to NO-stimulated cell death. This effect
was significant at 0.05 mM, 0.1 mM and 0.5 mM of SNP
(Figure 1). In particular, at 0.5 mM of SNP, nearly all
CCL cells were dead compared to CaCL cells (92% vs.
45%, P< 0.01). At concentration above 0.5 mM of SNP,
viability of CaCL cells as well decreased to nearly the
same amount of CCL cells. At high concentration of
SNP, such as 0.5 mM for CCL cells and 1 mM for CaCL
cells, the proportion of dead cells increases dramatically
that we assume cell death might have changed its shape
from apoptosis to necrosis. Although apoptosis and ne-
crosis are commonly regarded as conceptually distinct
modes of cell death, there is increasing evidence that the
two classical types of demise can occur simultaneously
in tissue or in cell cultures[26]. Thus, we used lower
concentrations of SNP to investigate different pathways.
The difference in susceptibility to apoptosis between the
two cruciate ligaments was also demonstrated with other
apoptosis inducer [24]. Measurement of the pro-survival
bcl-2 protein showed that the level decreased in associ-
ation with SNP treatment in a dose-dependent way
(Table 1). In healthy cells, basal levels of anti-apoptotic
proteins like bcl-2 protein promotes cell survival by in-
hibition adapters needed for activation of caspases that
dismantle the cell [27]. The effect of SNP on bcl-2 levels
in cruciate ligamentocytes is consistent with the effect
described in human OA chondrocytes [19].
Time course experiments demonstrated that at 0.5 mM,
SNP induced an earlier reduction of cell viability in CCL
cells than in CaCL cells (Figure 3). This time-dependent ef-
fect was significantly apparent at 12 to 24 h. This dose- and
time-dependent manner of apoptosis induction is closely in
agreement with different studies using SNP-generated NOate ligamentocytes. Cells were cultured with indicated concentrations
was measured by MTT assay and calculated with the formula reported
represent the mean± SD from at least three separate experiments of
CCL vs. CaCL at each indicated concentration.
Figure 2 Apoptotic fraction in canine cruciate ligament cells. Canine CCL and CaCL cells were stimulated with indicated concentrations of
SNP for 18 h. Apoptotic cells were measured by FITC-annexinV/propidium iodide double stained flow cytometry. The stacked bar graphs are
divided into two categories: patterned graphs (square with upper right to lower left fill) and (light shaded square) indicate the early apoptotic
fractions detected as cells stained annexin V positive and propidium iodide negative, plain-colored graphs (dark gray square and light gray
square) indicate the end stage apoptosis and death detected as cells stained annexin V and propidium iodide positive. The graphs data represent
the mean± SD from at least three separate experiments of four different cell donors, each performed in triplicates. * P< 0.05, ** P< 0.01 for
combined (early and late) apoptotic fractions of CCL or CaCL treated with SNP at each indicated concentration vs. control without SNP treatment.
Table 1 Dose-dependent effect of SNP with/without
inhibitors on bcl-2 protein level in canine CCL and CaCL
cells
bcl-2 [ng/mg protein]
CCL cells (n = 6) CaCL cells (n = 6)
Control 6.6 ± 0.3 7.0 ± 0.4
SNP (0.3 mM) 6.5 ± 0.1 5.1 ± 0.3*
SNP (0.5 mM) 5.5 ± 0.3* 4.9 ± 0.2*
SNP (1 mM) 2.8 ± 0.2** 3.9 ± 0.1**
SNP (0.5 mM) +Genistein (50 μM) 8.8 ± 0.2†† 10.9 ± 0.4††
SNP (0.5 mM) +Uric acid (0.5 mM) 7.8 ± 0.1†† 7.9 ± 0.1††
SNP (0.5 mM) + Taxifolin (50 μM) 7.6 ± 0.3† 6.7 ± 0.4†
SNP (0.5 mM) + PTIO (5 μM) 5.8 ± 0.2 5.1 ± 0.2
Data represent the means and standard deviations from two separate
experiments, n refers to the number of donors, and each performed in
triplicates. Bcl-2 protein was measured by enzyme immunoassay. *, P< 0.05,
**, P< 0.01 vs. control; †, P< 0.05, ††, P< 0.01 vs. SNP (0.5 mM); Dunnett`s
multiple comparison test.
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from stifle tissue [19-21]. In those studies, cell death was
clearly linked to the activation of the caspase cascade, as
inhibitors of caspase-3 or caspase-9 prevented the cells
from apoptosis. In canine cruciate ligamentocytes, induc-
tion of cell loss by SNP was only marginally prevented
when the cells were prestimulated for 2 h with 100 μM of
the pancaspase inhibitor zVAD.fmk (Table 2). Same results
were achieved in a recent study with other NO-donors such
as DETA or SNAP [24]. We then tested whether caspase-3
was activated by SNP. While caspase-3 processing was
induced by staurosporine which served as positive control,
no evidence for caspase-3 cleavage was found by immuno-
blotting in SNP-treated cruciate ligamentocytes in the con-
centration range in which apoptosis was measured by flow
cytometry (data not shown). These observations suggest a
participation of a caspase-independent cell death pathway
(CICD), which has been noticed in the presence of the
broad-spectrum caspase inhibitor [28]. Evidence suggests
the existence of CICD that is mediated by apoptosis-indu-
cing factor (AIF), a mitochondrial flavoprotein, which
translocates to the nucleus and induces chromatin conden-
sation and DNA fragmentation [29]. Typically, mitochon-
drial functions decline during CICD, although this is
generally a slower process than seen in apoptosis [30].
Role of mitogen-activated protein kinase, protein kinase
C, tyrosine kinase, and NF-kB inhibitors on SNP-induced
cruciate ligamentocyte death
MAP kinase is a family of enzymes that play an important
role in converting extracellular signals to intracellularmessengers that regulate several cellular phenomena, in-
cluding apoptotic cell death or survival [31]. The issue of
whether MAP kinase activation determines cell survival or
death remains controversial. Several studies indicate that
Mitogen activated protein kinase subtypes ERK1/2 are
activated in response to mitogen or growth factor stimula-
tion and that its activation is coupled with cell survival
[32,33]. The subtype p38 kinase is stimulated during cellu-
lar stress conditions and its activation is associated with
apoptosis [20,33]. Previous studies in humans and in ani-
mals like dogs or rabbits demonstrate that NO represent a
Figure 3 Time-dependent effect of SNP on canine cruciate ligamentocytes. The apoptotic cell number in canine CCL (dark gray square) and
□ CaCL cells was measured by flow cytometry. Cells were incubated in medium with 0.5 mM SNP for 6, 12, 18 and 24 h. Values correspond to
the mean± SD from at least three separate experiments of four different cell donors, each performed in triplicates. *, P< 0.05, **, P> 0.01 CCL vs.
CaCL at each indicated time.
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[19,20,34]. They demonstrated that exogenous or en-
dogenous NO induce the activation of MAP kinase p38
and ERK1/2 because interruption of the kinase signaling
by using ERK1/2 inhibitor (PD98059) and MAP kinase
p38 inhibitor (SB202190) significantly influenced apop-
tosis in two different directions. To elucidate the role of
potential upstream signaling molecules in canine cruciate
ligamentocytes, we used the same cell-permeable inhibi-
tors SB202190 and PD98059. Inhibition of ERK1/2 by
PD98059 (10 μM) caused death equally in both canine
cruciate ligamentocytes which was significantly pro-
nounced in case of a coincubation with SNP (Table 2).
This indicates that ERK1/2 function as anti-apoptotic sig-
nals in canine cruciate ligament cells which is in accord
with that reported for rabbit chondrocytes [20], but differ
from the reaction in human and canine OA chondrocytes
which in contrast could be protected against apoptosis by
using PD98059 [19,34]. Inhibition of p38 kinase with
SB202190 significantly block NO-induced apoptosis in
several cell types like human [19] and canine [34] OA
chondrocytes as well as normal rabbit chondrocytes [20].
However, in CCL and CaCL cells, the p38 inhibitor did
not reduce apoptosis excluding p38 kinase as a pro-apop-
totic signaling cascade upon NO. Blocking another signal-
ing cascade by calphostin C, cell loss through SNP was
not significantly inhibited in both canine cruciate ligamen-
tocytes, suggesting that SNP-induced cell death was not
mediated by protein kinase C. In contrast, this pathway is
activated in human OA chondrocytes and synoviocytes
[19,21]. To improve functionality of calphostin C, we per-
formed the same experiments on human OA chondro-
cytes which served as positive controls and could verify
the protective effect of these inhibitors as reported [19].In an attempt to elucidate the potential role of NF-kB
regulated apoptosis in canine cruciate ligamentocytes,
we used two inhibitors. SN-50 inhibits nuclear transloca-
tion of the activated NF-kB complex, whereas PDTC
prevents the activation of NF-kB. The activation of
NF-kB can have both preventative and causative roles in
the induction of apoptosis [35]. In our cells, PDTC
(10 μM) alone showed a significant reduction in viability
and reduced the number of viable cells below 5% after
SNP coincubation in CCL and CaCL cells. The effect
was enhanced by addition of SNP. An apoptosis-enhan-
cing capability was also seen when cells were treated
with SN-50 (50 μM) following coincubation with SNP
(Table 2) but the effect was less pronounced. This apop-
tosis–enhancing capability of NF-kB inhibitors is con-
sistent with studies on human OA chondrocytes [19].
Nitric oxide donors have the capacity to cause phos-
phorylation of various targets, including the tyrosine kin-
ase (TK). The TK family plays a key role in regulation of
cell proliferation, differentiation, metabolism, as well as
survival [36]. They catalyze the transfer of γ-phoshoryl
groups from ATP to tyrosine hydroxyls of proteins. The
phosphorylation of tyrosine residues modulates enzymatic
activity and creates binding sites for recruitment of down-
stream signaling proteins. The TK inhibitor genistein is
involved in different cell processes such as inhibition of
tumor cell proliferation, activation of tumor cell differenti-
ation as well as blocking oxidative DNA damage in vitro
[37,38]. Previous studies showed that blocking TK with
genistein was very effective in preventing apoptosis in
human OA chondrocytes and synoviocytes after SNP ex-
posure [19,21]. Likewise, in canine cruciate ligamento-
cytes, genistein markedly and dose-dependently preserved
cell viability in the presence of SNP (Table 2). The
Table 2 Cell viability of canine cruciate ligamentocytes in
response to different inhibitors and SNP treatment
Inhibitor
pretreatment
CCL cell viability (n = 8) CaCL cell viability (n = 8)
SNP treatment SNP treatment
- + - +
zVAD.fmk 0 100 ± 6.0 75.5 ± 3.1 100 ± 5.9 73.6 ± 2.4
100 μM 92.5 ± 5.3 84.5 ± 4.3 92.2 ± 6.3 88.2 ± 3.6*
CalC 0 100 ± 11.3 79.9 ± 5.3 100 ± 5.9 78.2 ± 7.2
25 nM 93.5 ± 6.9 73.4 ± 3.3 100 ± 6.0 68.7 ± 7.0
PD98059 0 100 ± 5.6 75.8 ±6.4 100 ± 4.1 74.7 ± 9. 3
10 μM 81.2 ± 7.2* 61.8 ± 3.1* 78.3 ± 7.2* 52.2 ± 9.2*
SB202190 0 100 ±11.3 73.4 ± 5.4 100 ± 6.0 74.2 ± 7.7
10 μM 74.2 ±2.1* 65.9 ± 4.5 75.2 ± 5.8* 79.8 ± 2.4
Genistein 0 100 ± 6.0 69.6 ± 6.1 100 ± 5.8 72.3 ± 5.7
50 μM 101± 6.4 97.4 ±9.3** 106.1 ±6.3 101.9 ± 2.5**
NS-398 0 100 ± 5.4 64.9 ± 3.6 100 ± 5.4 63.2 ± 4.1
50 μM 89.5 ± 17.7 78.1 ± 3.9* 88.5 ± 4.7* 88.8 ± 2.5**
100 μM 74.7 ± 14.4 75.3 ± 4.2* 81.8 ± 12.1 92.4 ± 2.7**
SN-50 0 100 ± 8.3 74.6 ± 3.8 100 ± 8.4 81.2 ± 2.4
50 μM 97.3 ± 8.6 64.4 ± 12.6 101.4 ± 4.5 67.3 ± 2.7*
PDTC 0 100 ± 8.3 74.6 ± 3.8 100 ± 8.4 81.2 ± 2.4
10 μM 42.7 ± 7.7** 5.5 ± 1.9** 43.8 ± 2.3** 2.1 ± 1.7**
Uric acid 0 100 ± 9.2 73.5 ± 5.4 100 ± 5.6 78.2 ± 2.4
0.5 mM 103.6 ± 9.5 102.7 ± 12.1* 101.9 ± 6.2 94.6 ± 5.9*
PTIO 0 100 ± 6.2 64.9 ± 2.6 100 ± 9.3 61.2 ± 4.6
5 μM 87.9 ± 7.3 80.9 ± 1.5* 96.2 ± 9.6 73.8 ± 3.2*
Taxifolin 0 100 ± 3.7 76.2 ± 4.2 100 ± 5.6 74.3 ± 7.7
100 μM 91.6 ± 11.5 84.8 ± 10.6 101.3 ± 4.1 97.3 ± 6.8*
Values correspond to the mean ± SD, calculated by using the formula from
M&M section of three separate experiments of n different cell donors, each
performed in triplicates. Cruciate ligamentocytes were preincubated with the
indicated concentrations of the inhibitors for 2 h. SNP or none SNP were then
added to the cultures and allowed to incubate for an additional 18-h period.
SNP concentrations used were 0.2 to 0.25 mM. Cell viability was assayed by
MTT assay. P-values indicate difference within the same type of cell and SNP
treatment versus absent inhibitor: *, P< 0.05; **, P< 0.01.
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CCL and CaCL but was the highest of all used specific
pharmacological inhibitors in our study. Even strong cyto-
toxic effects of high SNP concentrations (0.5 mM) were
effectively degraded (from about 80% apoptosis to less
than 20% in CCL and 13% in CaCL cells). Furthermore,
addition of genistein to CCL and CaCL cells exposed to
SNP resulted in a 1.6-fold and 2.2-fold increase in the bcl-
2 protein level, relative to cruciate ligamentocytes exposed
to SNP in the absence of the inhibitor (Table 1). Further-
more, the protection was associated with a complete inhi-
biton of PGE2 secretion. This implies that TK is an
important transducing pathway in regulating cellular sus-
ceptibility to NO in canine cruciate ligamentocytes, a find-
ing similar to that reported in human OA chondrocytes
and synoviocytes [19,21].Role of ROS in SNP-induced cruciate ligament cell death
In a previous study application of iNOS inhibitors was
not able to reduce apoptosis in CCLs in vivo [39] sug-
gesting NO does not feature the sole responsibility for
CCL cell apoptosis. Several possible systems have been
considered to explain the exact mechanisms of NO-
mediated cytotoxicity. Because of the potential of NO to
react with free radicals, we investigated whether SNP
caused toxicity directly, due to NO, or indirectly, due to
ROS formation. In the present study, ROS were found to
be a major activation pathway in SNP-induced cruciate
ligamentocyte cytotoxicity. We demonstrated that block-
ing generation of ROS significantly attenuate apoptosis.
Taxifolin, a scavenger of O2
- and H2O2, and the NO-
scavenger carboxy-PTIO significantly reduced death in
cranial as well as in caudal cruciate ligamentocytes
(Table 2). The most pronounced effect was reached by
using the ONOO- scavenger uric acid. Uric acid pro-
tected cruciate ligamentocytes against the toxic effect of
NO in a dose-dependent manner and significantly
increased their viability. In human OA, the uncontrolled
production of free radicals is considered an important
factor in the pathogenesis of OA [40,41]. Del Carlo and
Loeser demonstrated that chondrocyte cell death from
NO occurred only under conditions where other ROS
were concurrently generated [42]. The NO-scavenger
PTIO showed a protective effect on SNP-induced cell
death in human OA and normal chondrocytes, whereas
the ROS scavenger N-acetyl-L-cysteine profoundly
blocked DNA degradation in normal human chondro-
cytes [21,43]. On the level of bcl-2, ROS inhibitors like
uric acid and taxifolin prevented a downregulation of
bcl-2 protein in SNP-treated cruciate ligamentocytes
(Table 1).
Role of COX-2 and PGE2 in SNP-mediated cruciate
ligament cell death
In vivo and in vitro studies observed that iNOS and
COX-2 are induced in a number of inflammatory models
including human OA [19,21] and canine OA [34]. Based
on the potential crosstalk between the two systems and
the clinical usage of COX inhibitors in orthopedic dis-
eases in dogs, we were interested whether such a regula-
tion exists in stress-induced cruciate ligamentocytes as
well. The COX-2 inhibitor NS-398 (0–100 μM) dose-de-
pendently and significantly attenuated the cytotoxic ef-
fect of NO in both cruciate ligamentocytes (Table 2), but
it was less clearly than reported in human OA chondro-
cytes or synoviocytes where NS-398 totally abolished the
effect of NO [19,21]. In experimental OA in dogs, spe-
cific inhibition of COX-2 by NS-398 significantly
reduced the level of chondrocyte death [34].
Nitric oxide has the ability to activate COX-1 and
COX-2 enzymes and hence PG production [44].
Table 3 Dose-dependent effect of SNP and inhibitors on PGE2 production in canine CCL and CaCL cells
PGE2 [pg/mL/2× 10
6 cells]
Treatment CCL cells CaCL cells Human chondrocytes
Control 35.4 ± 0.1 29.0 ± 0.6 620± 10
SNP (0.2 mM) 90.1 ± 1.3* 81.8 ± 2.2* 995± 30*
SNP (0.4 mM) 134.2 ± 5.4* 91.6 ± 14.5*
SNP (0.5 mM) 247.2 ± 16.9* 108.6 ± 10.6* 1636 ± 22*
SNP (1.0 mM) 239.4 ± 12.6* 179.8 ± 8.2* 12790± 870*
SNP (0.2 mM) +Genistein (50 μM) 39.5 ± 3.4† 43.1 ± 2.3†
SNP (0.2 mM) +NS-398 (50 μM) 46.2 ± 2.1† 46.3 ± 3.8†
Data are the mean ± SD from two separate experiments each performed in triplicates. PGE2 release in pg of 2 × 10
6 cells into 1 mL medium was measured by
enzyme immunoassay. Human chondrocytes served as positive controls. *, P< 0.01 vs. control; †, P< 0.01 vs. SNP (0.2 mM); Dunnett`s multiple comparison test.
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released by constitutively expressed COX-1 and exert
beneficial cytoprotective effects, whereas high PG
concentrations were released by COX-2 at site of in-
flammation [45]. In canine cruciate ligament cells,
measurements of PGE2 concentrations showed that
endogenous PGE2 release was increased dose-de-
pendently by SNP treatment (Table 3). The amount
of PGE2 in cruciate ligamentocytes was significantly
lower compared to the amount in human OA chon-
drocytes measured in parallel (Table 3) but no differ-
ences were found between CCL and CaCL. As a
limitation of the study, we were not able to attribute
the increase of PGE2 to COX-1 or COX-2 activation
because we only performed COX-2 immunoblotting.
COX-2 expression was not detected in SNP-treated
canine cruciate ligament cells, but the quantity of
COX-2 protein was possibly below the detection
limit (data not shown). In contrast, in sections of ca-
nine OA cartilage COX-2 could be detected in situ
by immunohistochemistry [34]. These data suggest
that the COX-2 system exhibits a less important
regulator of NO-induced cell death in canine cruci-
ate ligament cells than for example in canine OA
chondrocytes [34]. The low concentrations of PGE2
and the undetectable COX-2 expression could be an
indication for a lower metabolic activity of cruciate
ligamentocytes in inflammatory processes. Investiga-
tion of PGE2 in cruciate ligamentocytes from dogs
with cruciate disease would be helpful to prove if a
low PG activity is phenotype (normal or OA cell) in-
dependent and hence specific in canine cruciate
ligamentocytes.
A possible limitation of our data is the fact that
we used cells from healthy joint tissue and compared
the results to published studies using healthy and
OA tissue. However, these studies show that the
same principle pathways exist in OA and healthy
cells independent on their phenotype but might have
different degree of activation [19,20,32,34].Conclusions
Canine cranial cruciate ligament cells clearly showed a
higher susceptibility to NO-induced apoptosis. Albeit we
could not find any significant differences between CCL
and CaCL cells in the tested pathways, suggesting that
the different susceptibility to apoptosis was not related
to these pathways. A comparison of canine cruciate liga-
ment cells with other cells from articular tissue demon-
strates that cruciate ligamentocytes have a specific
signaling on the stressor NO. Nitric oxide induced liga-
ment cell death seemed to be mediated multi-plain
whereupon TK and ROS play a major role. New efforts
to prevent the development and progression of OA may
include strategies and interventions aimed at reducing
oxidative damage. Further studies are necessary to clarify
if the inhibition of apoptosis in cruciate ligamentocytes
induced by NO or other stressors would be effective in
preservation ligament homeostasis. Until now the stand-
ard of care for CCL disease is surgical. With this study
in perspective, we open the discussion to the use of dis-
ease-modifying therapy as a less invasive procedure
offering a potential solution for CCL regeneration.
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